We are live on !
Find out more
GF
Gerry Farber Portfolio holdings
AUM
$76.8M
Turnover
78.95%
1-Year Est. Return
51.89%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+51.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76.8M
AUM Growth
-$19.6M
(-20%)
Cap. Flow
-$21.2M
Cap. Flow % of AUM
Cap. Flow %
-27.6%
Top 10 Holdings %
Top 10 Hldgs %
57.69%
Holding
76
New
15
Increased
9
Reduced
7
Closed
45
Avg Time Held
Equity + Options
0.2
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.2
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$5.36M |
| 2 |
Microsoft
MSFT
|
+$4.55M |
| 3 |
AbbVie
ABBV
|
+$3.41M |
| 4 |
Micron Technology
MU
|
+$3.01M |
| 5 |
Liberty Media Corporation Series A Common Stock
FWONA
|
+$2.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gentherm
THRM
|
+$4.43M |
| 2 |
Alkermes
ALKS
|
+$4.18M |
| 3 |
Meta Platforms (Facebook)
META
|
+$3.73M |
| 4 |
ROSE
ROSETTA RESOURCES INC
ROSE
|
+$3.21M |
| 5 |
Abercrombie & Fitch
ANF
|
+$2.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.88% |
| 2 | Technology | 18.85% |
| 3 | Communication Services | 11.63% |
| 4 | Consumer Discretionary | 11.25% |
| 5 | Miscellaneous | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $7.43M | 9.68% |
30,800
+3,100
| +11% | +$694K |
2014 Q1
2 quarters
|
|
|
AGN
2
DELISTED
Allergan Inc
AGN
| $7.04M | 9.17% |
39,500
+32,300
| +449% | +$5.36M |
2014 Q1
2 quarters
|
|
|
3
Microsoft
MSFT
$3.96T
| $4.73M | 6.16% |
+102,000
| New | +$4.55M |
2014 Q3
0 quarters
|
|
4
DELISTED
ODP
ODP
| $4.09M | 5.32% |
79,500
+7,000
| +10% | +$370K |
2014 Q2
1 quarter
|
|
5
Bausch Health
BHC
$2.41B
| $3.58M | 4.67% |
27,300
+12,800
| +88% | +$1.53M |
2014 Q2
1 quarter
|
|
6
DELISTED
SANDISK CORP
SNDK
| $3.58M | 4.66% |
36,500
+24,400
| +202% | +$2.39M |
2014 Q2
1 quarter
|
|
|
7
AbbVie
ABBV
$503B
| $3.55M | 4.62% |
+61,400
| New | +$3.41M |
2014 Q3
0 quarters
|
|
|
LGF
8
DELISTED
Lions Gate Entertainment
LGF
| $3.54M | 4.62% |
107,500
+19,700
| +22% | +$625K |
2014 Q1
2 quarters
|
|
9
Gilead Sciences
GILD
$190B
| $3.48M | 4.53% |
32,700
+1,400
| +4% | +$137K |
2014 Q2
1 quarter
|
|
10
Pfizer
PFE
$170B
| $3.28M | 4.27% |
116,783
+29,512
| +34% | +$828K |
2013 Q2
5 quarters
|
|
|
11
Micron Technology
MU
$1.03T
| $3.19M | 4.15% |
+93,000
| New | +$3.01M |
2014 Q3
0 quarters
|
|
|
12
Liberty Media Corporation Series A Common Stock
FWONA
$21B
| $2.72M | 3.55% |
+113,365
| New | +$2.78M |
2014 Q3
0 quarters
|
|
13
NXP Semiconductors
NXPI
$61.1B
| $2.33M | 3.03% |
34,000
-33,500
| -50% | -$2.23M |
2014 Q2
1 quarter
|
|
14
Axon Enterprise
AXON
$32.7B
| $2.01M | 2.62% |
+130,200
| New | +$1.84M |
2014 Q3
0 quarters
|
|
15
Acadia Healthcare
ACHC
$2.93B
| $1.99M | 2.6% |
41,100
+14,100
| +52% | +$689K |
2014 Q2
1 quarter
|
|
16
HP
HPQ
$28.2B
| $1.84M | 2.4% |
+114,284
| New | +$1.85M |
2014 Q3
0 quarters
|
|
|
AKRX
17
DELISTED
Akorn Inc
AKRX
| $1.76M | 2.29% |
48,500
-27,800
| -36% | -$996K |
2014 Q2
1 quarter
|
|
18
Merck
MRK
$370B
| $1.73M | 2.25% |
30,602
-14,672
| -32% | -$824K |
2014 Q1
2 quarters
|
|
|
EMWP
19
DELISTED
Eros Media World PLC
EMWP
| $1.41M | 1.84% |
+4,835
| New | +$1.48M |
2014 Q3
0 quarters
|
|
|
TNAV
20
DELISTED
Telenav Inc.
TNAV
| $1.41M | 1.83% |
+209,900
| New | +$1.29M |
2014 Q3
0 quarters
|
|
21
Cinemark Holdings
CNK
$4.63B
| $1.25M | 1.63% |
+36,800
| New | +$1.28M |
2014 Q3
0 quarters
|
|
|
TUES
22
DELISTED
Tuesday Morning Corp
TUES
| $1.24M | 1.62% |
+64,100
| New | +$1.14M |
2014 Q3
0 quarters
|
|
|
N
23
DELISTED
Netsuite Inc
N
| $1.22M | 1.59% |
13,600
-4,500
| -25% | -$382K |
2014 Q2
1 quarter
|
|
|
MDVN
24
DELISTED
MEDIVATION, INC.
MDVN
| $1.21M | 1.57% |
+24,400
| New | +$1.04M |
2014 Q3
0 quarters
|
|
25
VF Corp
VFC
$6.74B
| $1.2M | 1.57% |
+19,328
| New | +$1.16M |
2014 Q3
0 quarters
|
|
Similar funds
DMAM
BCM
WRIP
BP
EWP
Gerry Farber's Q3 2014 Portfolio in Review
As of Q3 2014, Gerry Farber held 76 positions worth $76.8M, down 20% from $96.4M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Gerry Farber withdrew a net $21.2M in Q3 2014, closing 45 positions and reducing 7 holdings. Its most notable exit was Alkermes, an estimated $4.18M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Gerry Farber opened a new position in Microsoft worth $4.73M.
- Gerry Farber's largest Q3 2014 buy was Microsoft: 102,000 shares worth $4.73M.
- Gerry Farber added most to Allergan Inc in Q3 2014, an estimated $5.36M increase.
- Gerry Farber's biggest Q3 2014 reduction was Gentherm, cutting an estimated $4.43M.
- Gerry Farber fully exited Alkermes in Q3 2014, selling an estimated $4.18M.
- Gerry Farber's ten largest holdings make up 58% of its $76.8M portfolio in Q3 2014.
- Gerry Farber opened 15 new positions and closed 45 in Q3 2014.
- Gerry Farber's portfolio value fell 20% quarter-over-quarter to $76.8M.
Based on Gerry Farber's 13F filing for Q3 2014, filed 17 Oct 2014.